Anders Karlén

6.5k total citations · 1 hit paper
124 papers, 4.3k citations indexed

About

Anders Karlén is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Anders Karlén has authored 124 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 33 papers in Infectious Diseases and 27 papers in Organic Chemistry. Recurrent topics in Anders Karlén's work include Chemical Synthesis and Analysis (26 papers), Receptor Mechanisms and Signaling (25 papers) and Computational Drug Discovery Methods (24 papers). Anders Karlén is often cited by papers focused on Chemical Synthesis and Analysis (26 papers), Receptor Mechanisms and Signaling (25 papers) and Computational Drug Discovery Methods (24 papers). Anders Karlén collaborates with scholars based in Sweden, India and Belgium. Anders Karlén's co-authors include Anders Hallberg, Ursula Theuretzbacher, Kevin Outterson, Hans Lennernäs, Susanne Winiwarter, Gunnar Lindeberg, Nicholas M. Bonham, U. Helena Danielson, Wesley Schaal and Fred Nyberg and has published in prestigious journals such as Journal of Molecular Biology, Nature Reviews Drug Discovery and Nature Reviews Microbiology.

In The Last Decade

Anders Karlén

119 papers receiving 4.2k citations

Hit Papers

The global preclinical antibacterial pipeline 2019 2026 2021 2023 2019 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The global preclinical antibacterial pipeline
    2019 524 citations Anders Karlén et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Karlén Sweden 35 2.2k 1.1k 740 481 443 124 4.3k
Mark B. Swindells United Kingdom 27 5.2k 2.3× 802 0.7× 1.0k 1.4× 597 1.2× 155 0.3× 50 7.6k
Bruno O. Villoutreix France 49 3.9k 1.8× 907 0.8× 2.3k 3.1× 560 1.2× 261 0.6× 221 8.5k
Michael A. Walters United States 29 2.2k 1.0× 1.1k 1.0× 633 0.9× 261 0.5× 124 0.3× 98 5.0k
Andrew C. Wallace United States 11 5.0k 2.2× 887 0.8× 909 1.2× 563 1.2× 95 0.2× 12 7.0k
Chresten R. Søndergaard Ireland 9 3.7k 1.7× 587 0.5× 716 1.0× 335 0.7× 87 0.2× 12 5.3k
Alexander W. Schüttelkopf United Kingdom 25 4.1k 1.9× 1.3k 1.2× 787 1.1× 485 1.0× 69 0.2× 32 6.3k
Patrick J. Loll United States 34 2.4k 1.1× 835 0.8× 234 0.3× 245 0.5× 302 0.7× 88 4.5k
Paul C. Sanschagrin United States 13 4.3k 2.0× 1.4k 1.3× 2.0k 2.7× 643 1.3× 99 0.2× 14 6.9k
G. Madhavi Sastry India 16 3.1k 1.4× 1.1k 1.0× 1.6k 2.2× 498 1.0× 59 0.1× 27 5.3k
Daniel Bur Switzerland 32 1.5k 0.7× 1.0k 0.9× 462 0.6× 161 0.3× 288 0.7× 88 2.9k

Countries citing papers authored by Anders Karlén

Since Specialization
Citations

This map shows the geographic impact of Anders Karlén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Karlén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Karlén more than expected).

Fields of papers citing papers by Anders Karlén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Karlén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Karlén. The network helps show where Anders Karlén may publish in the future.

Co-authorship network of co-authors of Anders Karlén

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Karlén. A scholar is included among the top collaborators of Anders Karlén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Karlén. Anders Karlén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Sha, Bo Lundgren, Katharina Klöditz, et al.. (2024). Design, synthesis, and in vitro biological evaluation of meta-sulfonamidobenzamide-based antibacterial LpxH inhibitors. European Journal of Medicinal Chemistry. 278. 116790–116790. 1 indexed citations
2.
Karlén, Anders, et al.. (2022). Bacterial type I signal peptidase inhibitors - Optimized hits from nature. European Journal of Medicinal Chemistry. 238. 114490–114490. 14 indexed citations
3.
Grinkevich, Vera, Natalia Issaeva, Virginia Andreotti, et al.. (2022). Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule. Frontiers in Molecular Biosciences. 9. 823195–823195. 5 indexed citations
4.
5.
Karlén, Anders, et al.. (2017). Predicting the Rate of Skin Penetration Using an Aggregated Conformal Prediction Framework. Molecular Pharmaceutics. 14(5). 1571–1576. 12 indexed citations
6.
Åkerblom, Eva, et al.. (2011). P2–P1′ macrocyclization of P2 phenylglycine based HCV NS3 protease inhibitors using ring-closing metathesis. Bioorganic & Medicinal Chemistry. 19(16). 4917–4927. 9 indexed citations
7.
Bjorkelid, C., et al.. (2011). Substitution of the phosphonic acid and hydroxamic acid functionalities of the DXR inhibitor FR900098: An attempt to improve the activity against Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry Letters. 21(18). 5403–5407. 22 indexed citations
8.
Ericsson, Daniel J., et al.. (2010). Identification of small peptides mimicking the R2 C‐terminus of Mycobacterium tuberculosis ribonucleotide reductase. Journal of Peptide Science. 16(3). 159–164. 7 indexed citations
9.
Nilsson, Mikael, Wojciech Krajewski, B. R. Srinivasa, et al.. (2009). Structural Basis for the Inhibition of Mycobacterium tuberculosis Glutamine Synthetase by Novel ATP-Competitive Inhibitors. Journal of Molecular Biology. 393(2). 504–513. 41 indexed citations
10.
Axén, Andreas, Hanna Andersson, Gunnar Lindeberg, et al.. (2007). Small potent ligands to the insulin‐regulated aminopeptidase (IRAP)/AT4 receptor. Journal of Peptide Science. 13(7). 434–444. 30 indexed citations
11.
Odell, Luke R., Sherry L. Mowbray, Mikael Nilsson, et al.. (2007). Microwave-Enhanced α-Arylation of a Protected Glycine in Water:Evaluation of 3-Phenylglycine Derivatives as Inhibitors of the Tuberculosis Enzyme, Glutamine Synthetase. Combinatorial Chemistry & High Throughput Screening. 10(9). 783–789. 9 indexed citations
12.
Luzhkov, Victor B., Barbara Selisko, Anneli Nordqvist, et al.. (2007). Virtual screening and bioassay study of novel inhibitors for dengue virus mRNA cap (nucleoside-2′O)-methyltransferase. Bioorganic & Medicinal Chemistry. 15(24). 7795–7802. 63 indexed citations
13.
Sköld, Christian, Gregory V. Nikiforovich, & Anders Karlén. (2007). Modeling binding modes of angiotensin II and pseudopeptide analogues to the AT2 receptor. Journal of Molecular Graphics and Modelling. 26(6). 991–1003. 7 indexed citations
14.
Sköld, Christian & Anders Karlén. (2006). Development of CoMFA models of affinity and selectivity to angiotensin II type-1 and type-2 receptors. Journal of Molecular Graphics and Modelling. 26(1). 145–153. 2 indexed citations
15.
Erdélyi, Máté, Anders Karlén, & Adolf Gogoll. (2005). A New Tool in Peptide Engineering: A Photoswitchable Stilbene‐type β‐Hairpin Mimetic. Chemistry - A European Journal. 12(2). 403–412. 32 indexed citations
16.
Rosenström, Ulrika, Gunnar Lindeberg, M.E. Botros, et al.. (2004). Synthesis and AT2 receptor‐binding properties of angiotensin II analogues. Journal of Peptide Research. 64(5). 194–201. 22 indexed citations
17.
Hämäläinen, Markku, Per-Olof Markgren, Wesley Schaal, et al.. (2000). Characterization of a Set of HIV-1 Protease Inhibitors Using Binding Kinetics Data from a Biosensor-Based Screen. SLAS DISCOVERY. 5(5). 353–359. 37 indexed citations
18.
Lindeberg, Gunnar, et al.. (2000). Comparison of three γ-turn mimetic scaffolds incorporated into angiotensin II. Bioorganic & Medicinal Chemistry. 8(9). 2375–2383. 18 indexed citations
19.
20.
Mellin, Charlotta, Anders Karlén, Anette M. Johansson, et al.. (1988). Central dopaminergic and 5-hydroxytryptaminergic effects of C(3)-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin. Journal of Medicinal Chemistry. 31(6). 1130–1140. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark B. Swindells Breakdown of academic impact, for papers by Bruno O. Villoutreix Breakdown of academic impact, for papers by Michael A. Walters Breakdown of academic impact, for papers by Andrew C. Wallace Breakdown of academic impact, for papers by Chresten R. Søndergaard Breakdown of academic impact, for papers by Alexander W. Schüttelkopf Breakdown of academic impact, for papers by Patrick J. Loll Breakdown of academic impact, for papers by Paul C. Sanschagrin Breakdown of academic impact, for papers by G. Madhavi Sastry Breakdown of academic impact, for papers by Daniel Bur
Rankless by CCL
2026